Alberto Mantovani, ALBERTO MANTOVANI

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Macrophage Pharma
    Topic:
    Advisory Board Member
    Date added:
    10/05/2023
    Date updated:
    10/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Biovelocita
    Topic:
    Advisory Board Member
    Date added:
    10/05/2023
    Date updated:
    10/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    Consultancy
    Date added:
    10/05/2023
    Date updated:
    10/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Olatec Thera
    Topic:
    Advisory Board Member
    Date added:
    10/05/2023
    Date updated:
    10/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Moderna
    Topic:
    Advisory Board Member
    Date added:
    10/05/2023
    Date updated:
    10/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Henlius
    Topic:
    Advisory Board Member
    Date added:
    10/05/2023
    Date updated:
    10/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Biolegend
    Topic:
    Advisory Board Member
    Date added:
    10/05/2023
    Date updated:
    10/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other Business Ownership
    Ineligible company:
    Cedarlane
    Topic:
    royalties from sale of reagents
    Date added:
    10/05/2023
    Date updated:
    10/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other Business Ownership
    Ineligible company:
    Hycult
    Topic:
    royalties from sale of reagents
    Date added:
    10/05/2023
    Date updated:
    10/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other Business Ownership
    Ineligible company:
    Biolegend
    Topic:
    royalties from sale of reagents
    Date added:
    10/05/2023
    Date updated:
    10/05/2023

Pages

Return to American Autonomic Society 2023 Annual Meeting (JS2311B)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.